Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard A Norman

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Trends in Pharmacological Sciences|April 17, 2012
Structural approaches to obtain kinase selectivityRichard A Norman, Dorin Toader, Andrew D Ferguson
ACS Medicinal Chemistry Letters|June 6, 2014
FGFR1 Kinase Inhibitors: Close Regioisomers Adopt Divergent Binding Modes and Display Distinct Biophysical SignaturesTobias Klein, Julie Tucker, Geoffrey A Holdgate, et al.
Structure (London, England : 1993)|December 4, 2014
Structural insights into FGFR kinase isoform selectivity: diverse binding modes of AZD4547 and ponatinib in complex with FGFR1 and FGFR4Julie A Tucker, Tobias Klein, Jason Breed, et al.
Structure (London, England : 1993)|May 15, 2002
Crystal structure of inositol 1-phosphate synthase from Mycobacterium tuberculosis, a key enzyme in phosphatidylinositol synthesisRichard A Norman, Mark S B McAlister, Judith Murray-Rust, et al.
Briefings in Bioinformatics|October 19, 2019
Computational approaches to therapeutic antibody design: established methods and emerging trendsRichard A Norman, Francesco Ambrosetti, Alexandre M J J Bonvin, et al.
Rapid Communications in Mass Spectrometry : RCM|May 26, 2021
Validation of ion mobility spectrometry - mass spectrometry as a screening tool to identify type II kinase inhibitors of FGFR1 kinaseHelen S Beeston, Tobias Klein, Richard A Norman, et al.
Bioscience Reports|July 19, 2013
Characterization of the complex formed between a potent neutralizing ovine-derived polyclonal anti-TNFα Fab fragment and human TNFαW Mark Abbott, Melanie Snow, Sonia Eckersley, et al.
Journal of Medicinal Chemistry|September 10, 2009
Rapid generation of a high quality lead for transforming growth factor-beta (TGF-beta) type I receptor (ALK5)Frederick W Goldberg, Richard A Ward, Steven J Powell, et al.
ACS Medicinal Chemistry Letters|January 29, 2016
Tetrahydroisoquinoline Phenols: Selective Estrogen Receptor Downregulator Antagonists with Oral Bioavailability in RatJames S Scott, Andrew Bailey, Robert D M Davies, et al.
Nature Communications|July 24, 2015
Structural and dynamic insights into the energetics of activation loop rearrangement in FGFR1 kinaseTobias Klein, Navratna Vajpai, Jonathan J Phillips, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Trends in Pharmacological Sciences|April 17, 2012
Structural approaches to obtain kinase selectivityRichard A Norman, Dorin Toader, Andrew D Ferguson
ACS Medicinal Chemistry Letters|June 6, 2014
FGFR1 Kinase Inhibitors: Close Regioisomers Adopt Divergent Binding Modes and Display Distinct Biophysical SignaturesTobias Klein, Julie Tucker, Geoffrey A Holdgate, et al.
Structure (London, England : 1993)|December 4, 2014
Structural insights into FGFR kinase isoform selectivity: diverse binding modes of AZD4547 and ponatinib in complex with FGFR1 and FGFR4Julie A Tucker, Tobias Klein, Jason Breed, et al.
Structure (London, England : 1993)|May 15, 2002
Crystal structure of inositol 1-phosphate synthase from Mycobacterium tuberculosis, a key enzyme in phosphatidylinositol synthesisRichard A Norman, Mark S B McAlister, Judith Murray-Rust, et al.
Briefings in Bioinformatics|October 19, 2019
Computational approaches to therapeutic antibody design: established methods and emerging trendsRichard A Norman, Francesco Ambrosetti, Alexandre M J J Bonvin, et al.
Rapid Communications in Mass Spectrometry : RCM|May 26, 2021
Validation of ion mobility spectrometry - mass spectrometry as a screening tool to identify type II kinase inhibitors of FGFR1 kinaseHelen S Beeston, Tobias Klein, Richard A Norman, et al.
Bioscience Reports|July 19, 2013
Characterization of the complex formed between a potent neutralizing ovine-derived polyclonal anti-TNFα Fab fragment and human TNFαW Mark Abbott, Melanie Snow, Sonia Eckersley, et al.
Journal of Medicinal Chemistry|September 10, 2009
Rapid generation of a high quality lead for transforming growth factor-beta (TGF-beta) type I receptor (ALK5)Frederick W Goldberg, Richard A Ward, Steven J Powell, et al.
ACS Medicinal Chemistry Letters|January 29, 2016
Tetrahydroisoquinoline Phenols: Selective Estrogen Receptor Downregulator Antagonists with Oral Bioavailability in RatJames S Scott, Andrew Bailey, Robert D M Davies, et al.
Nature Communications|July 24, 2015
Structural and dynamic insights into the energetics of activation loop rearrangement in FGFR1 kinaseTobias Klein, Navratna Vajpai, Jonathan J Phillips, et al.
Pageof 3